BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
MDM2
,
Apoptosis
,
Influenza
,
Leukocyte
,
Personalized medicine
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IDH 1
Summary
General Info
Curated Studies
Most Correlated Studies
Isocitrate Dehydrogenase (IDH) Mutations in HCT116 isogenic clones
Hemocytes from wandering 3rd instar larvae misexpressing the Idh-R195H mutation
Astrocytes with IDH1 R132H expression doxycycline induced and withdrawn
Acute myeloid leukemia (AML) allografts with mutant IDH2-R14Q conditional deletion
Lower-grade diffuse astrocytic glioma expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Differentiating Inhibition Selectivity and Binding Affinity of Isocitrate Dehydrogenase 1 Variant In…
The roles of IDH1 in tumor metabolism and immunity.
The difficulty of aligning intrinsically disordered protein sequences as assessed by conservation an…
Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor.
Oncogenic IDH1 Mutation Imparts Therapeutically Targetable Metabolic Dysfunction in Multiple Tumor T…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive Enhancing IDH-1 Mutan…
Niraparib In Recurrent IDH 1/2 Gliomas
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ